市場調査レポート

結核検査の世界市場 2014〜2020年:業界分析、規模、シェア、成長、動向および予測

Tuberculosis Testing Market (Smear Microscopy, Culture Based Tests, Nucleic Acid Testing, Mantoux Test, Radiography (Chest X-Ray), Drug Susceptibility Testing & Other TB Tests) Global Industry Analysis, Size, Share, Growth, Trends & Forecast 2014 - 2020

発行 Transparency Market Research 商品コード 328539
出版日 ページ情報 英文 109 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.18円で換算しております。
Back to Top
結核検査の世界市場 2014〜2020年:業界分析、規模、シェア、成長、動向および予測 Tuberculosis Testing Market (Smear Microscopy, Culture Based Tests, Nucleic Acid Testing, Mantoux Test, Radiography (Chest X-Ray), Drug Susceptibility Testing & Other TB Tests) Global Industry Analysis, Size, Share, Growth, Trends & Forecast 2014 - 2020
出版日: 2015年03月23日 ページ情報: 英文 109 Pages
概要

結核 (TB) は伝染性の高い疾患であり、ヒト型結核菌または MTB (ヒト結核菌) 感染が原因となり、主にヒトの肺に感染します。患者の多くは結核の二つの型:活動性結核と潜伏性結核を患っています。結核は感染部位に基づいて、肺結核 (肺) 、骨格系結核 (骨・関節) 、胸膜結核、リンパ節結核、消化器結核、および結核性髄膜炎などいくつかのタイプがあります。肺結核は最も伝染性が高い疾患で、世界で多くの人に影響を与えています。

当レポートでは、世界の結核検査市場について調査し、市場収益の実績・予測を提供しており、市場の促進因子・阻害因子の分析、検査タイプ・地域別の分析と予測、競合情勢、および主要企業のプロファイルなどをまとめ、お届けいたします。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 世界の結核検査市場概要

  • イントロダクション
  • 市場促進因子
  • 市場阻害因子
  • 市場機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析
  • 市場の魅力度分析
  • 競合情勢

第4章 世界の結核検査市場:検査タイプ別

  • イントロダクション
  • スミア顕微鏡
  • 培養型検査
  • 核酸検査
  • ツベルクリン反応検査 (TST)
  • 放射線 (胸部X線)
  • 薬剤感受性試験 (DST)
  • その他の検査 (血清検査、IGRA、ほか)

第5章 世界の結核検査市場:地域別

  • 概要
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他 (ROW)

第6章 提言

  • さまざまなTB診断検査の価格統制の強調
  • ラボ機能・インフラの改善に向けて増加する政府投資の獲得への注力
  • アジア太平洋地域・その他 (ROW) 地域の新興市場をターゲットに

第7章 企業プロファイル

  • Abbott Laboratories
  • Akonni Biosystems, Inc.
  • Alere, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Cepheid
  • Epistem Holdings Plc
  • Hain Lifescience GmbH
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Sanofi
  • Thermo Fisher Scientific, Inc.
  • QIAGEN

図表

目次

This report on tuberculosis testing studies the current as well as future prospects of the market globally. Tuberculosis (TB) is a highly contagious disease, and is caused due to Mycobacterium tuberculosis or MTB infection and majorly infects human lungs. People majorly suffer from two forms of TB: active tuberculosis and latent tuberculosis. The several types of TB based on the site of infection are pulmonary TB (lungs), skeletal TB (bone and joints), pleural TB, lymph node TB, gastrointestinal TB, and TB meningitis. Pulmonary TB is the most contagious disease and affects a large number of individuals globally. Based on types of tests, the tuberculosis testing market has been segmented into seven major categories: smear microscopy, culture-based tests, nucleic acid testing, Mantoux test or tuberculin skin tests (TST), radiography (chest x-ray), drug susceptibility testing (DST) and other TB tests.

This report comprises an elaborate executive summary that includes a market snapshot that provides overall information of various segments and sub-segments included in the study scope. This section also provides overall information and data analysis of the global tuberculosis testing market with respect to leading market segments based on types of tests as well as different geographic regions. The respective markets for the considered tuberculosis tests have been extensively analyzed on the basis of their usefulness, effectiveness, sales revenue and geographic presence. The market size and forecast in terms of USD million for each type of test has been provided for the period from 2012 to 2020. This report on tuberculosis testing market also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2014 to 2020, considering 2013 as the base year.

Geographically, the global tuberculosis testing market has been categorized into four major regions: North America, Europe, Asia Pacific and Rest of the World (RoW). The market size and forecast for each of these regions have been provided for the period from 2012 to 2020, along with CAGR (%) for the forecast period from 2014 to 2020. The four major geographic markets have been further divided into seven sub-segments (major TB tests). The market size and forecast for each of these sub-segments have been provided for the period from 2012 to 2020, along with CAGR (%) for the forecast period from 2014 to 2020. The study also incorporates the competitive scenario in these regions.

A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global tuberculosis testing market and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis and Porter's five forces analysis and key players' market share and product wise heat map analysis in 2013 for the global TB testing market.

A list of recommendations has been provided for new entrants as well as existing market players to help establish a strong presence in the market and increase their market share. The report also profiles major players in the tuberculosis testing market on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major players profiled in this report include Abbott Laboratories, Akonni Biosystems, Inc., Alere, Inc., Becton, Dickinson and Company, bioMérieux SA, Cepheid, Epistem plc, F. Hoffmann-La Roche Ltd., Hain Lifescience GmbH, Hologic, QIAGEN, Sanofi and Thermo Fisher Scientific, Inc.

The global tuberculosis testing market is segmented as follows:

Tuberculosis Testing Market, by Test Type

  • Smear Microscopy
  • Culture Based Tests
  • Nucleic Acid Testing
  • Mantoux Test (Tuberculin Skin Test)
  • Radiography (Chest X-Ray)
  • Drug Susceptibility Testing (DST)
  • Other Tests (Serological Tests, IGRA, ADA, etc.)

Tuberculosis Testing Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

Chapter 1 Introduction

  • 1.1 Report Description
  • 1.2 Market Segmentation
  • 1.3 Research Methodology

Chapter 2 Executive Summary

  • 2.1 Market Snapshot: Global Tuberculosis Testing Market
  • 2.2 Comparative Analysis: Global Tuberculosis Testing Market Revenue, by Geography, 2013 & 2020 (Value %)

Chapter 3 Global Tuberculosis Testing Market Overview

  • 3.1 Introduction
    • 3.1.1 Epidemiology: Tuberculosis
    • 3.1.2 TB Incidence
    • 3.1.3 Diagnosis and Treatment
  • 3.2 Market Drivers
    • 3.2.1 Increased Acceptance of Various TB Testing Techniques due to High Prevalence and Incidence Rates of the Disease Globally
    • 3.2.2 Tuberculosis Awareness and Control Programs from Government and Non-Government Organizations Worldwide Likely to Fuel Growth in Demand for Various TB Tests
    • 3.2.3 Rising Demand for New, Improved, and Technologically Advanced Tuberculosis Testing Procedures and Equipment
  • 3.3 Market Restraints
    • 3.3.1 High Cost of Various Tuberculosis Tests may Affect the Overall Global Demand
  • 3.4 Market Opportunities
    • 3.4.1 Presence of a Huge Potential Market in Most of the Emerging Nations of the World
  • 3.5 Porter's Five Forces Analysis: Global Tuberculosis Testing Market
    • 3.5.1 Bargaining Power of Suppliers
    • 3.5.2 Bargaining Power of Buyers
    • 3.5.3 Threat of Substitutes
    • 3.5.4 Threat of New Entrants
    • 3.5.5 Competitive Rivalry
  • 3.6 Value Chain Analysis: Tuberculosis Testing Market
  • 3.7 Market Attractiveness Analysis: Global Tuberculosis Testing Market, by Geography
  • 3.8 Competitive Landscape
    • 3.8.1 Market Share Analysis, by Key Players: Global Tuberculosis Testing Market, 2013 (Value %)
    • 3.8.2 Heat Map Analysis: Global Tuberculosis Testing Market, by Key Players

Chapter 4 Global Tuberculosis Testing Market, by Test Type

  • 4.1 Introduction
    • 4.1.1 Global Tuberculosis Testing Market Revenue, by Test Type, 2012 - 2020 (USD Million)
    • 4.1.2 Comparative Analysis: Global Tuberculosis Testing Market, by Test Type, 2013 & 2020 (Value %)
  • 4.2 Smear Microscopy
    • 4.2.1 Global Smear Microscopy (TB Testing) Market Revenue, 2012 - 2020 (USD Million)
  • 4.3 Culture Based Tests
    • 4.3.1 Global Culture Based Tests (TB Testing) Market Revenue, 2012 - 2020 (USD Million)
  • 4.4 Nucleic Acid Testing
    • 4.4.1 Global Nucleic Acid Testing (TB Testing) Market Revenue, 2012 - 2020 (USD Million)
  • 4.5 Mantoux Test (Tuberculin Skin Test (TST))
    • 4.5.1 Global Tuberculin Skin Tests Market Revenue, 2012 - 2020 (USD Million)
  • 4.6 Radiography (Chest X-Ray)
    • 4.6.1 Global Radiography (Chest X-Ray) Market Revenue, 2012 - 2020 (USD Million)
  • 4.7 Drug Susceptibility Testing (DST)
    • 4.7.1 Global Drug Susceptibility Testing Market Revenue, 2012 - 2020 (USD Million)
  • 4.8 Other Tests (Serological Tests, IGRA, etc.)
    • 4.8.1 Global Other TB Testing Market Revenue, 2012 - 2020 (USD Million)

Chapter 5 Global Tuberculosis Testing Market, by Geography

  • 5.1 Overview
    • 5.1.1 Global Tuberculosis Testing Market Revenue, by Geography, 2012 - 2020 (USD Million)
  • 5.2 North America
    • 5.2.1 North America Tuberculosis Testing Market Revenue, 2012 - 2020 (USD Million)
    • 5.2.2 North America Tuberculosis Testing Market Revenue, by Test Type, 2012 - 2020 (USD Million)
  • 5.3 Europe
    • 5.3.1 Europe Tuberculosis Testing Market Revenue, 2012 - 2020 (USD Million)
    • 5.3.2 Europe Tuberculosis Testing Market Revenue, by Test Type, 2012 - 2020 (USD Million)
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Tuberculosis Testing Market Revenue, 2012 - 2020 (USD Million)
    • 5.4.2 Asia Pacific Tuberculosis Testing Market Revenue, by Test Type, 2012 - 2020 (USD Million)
  • 5.5 Rest of the World (RoW)
    • 5.5.1 RoW Tuberculosis Testing Market Revenue, 2012 - 2020 (USD Million)
    • 5.5.2 RoW Tuberculosis Testing Market Revenue, by Test Type, 2012 - 2020 (USD Million)

Chapter 6 Recommendations

  • 6.1 Emphasize on Price Control of Various TB Diagnostic Tests
  • 6.2 Focus on Obtaining Increased Government Investments for the Improvement of Laboratory Capacities and Infrastructure
  • 6.3 Target Emerging Markets of Asia Pacific and RoW

Chapter 7 Company Profiles

  • 7.1 Abbott Laboratories
    • 7.1.1 Company Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Product Portfolio
    • 7.1.4 Business Strategies
    • 7.1.5 Recent Developments
  • 7.2 Akonni Biosystems, Inc.
    • 7.2.1 Company Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Product Portfolio
    • 7.2.4 Business Strategies
    • 7.2.5 Recent Developments
  • 7.3 Alere, Inc.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Product Portfolio
    • 7.3.4 Business Strategies
    • 7.3.5 Recent Developments
  • 7.4 Becton, Dickinson and Company
    • 7.4.1 Company Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Product Portfolio
    • 7.4.4 Business Strategies
    • 7.4.5 Recent Developments
  • 7.5 bioMérieux SA
    • 7.5.1 Company Overview
    • 7.5.2 Financial Overview
    • 7.5.3 Product Portfolio
    • 7.5.4 Business Strategies
    • 7.5.5 Recent developments
  • 7.6 Cepheid
    • 7.6.1 Company Overview
    • 7.6.2 Financial Overview
    • 7.6.3 Product Portfolio
    • 7.6.4 Business Strategies
    • 7.6.5 Recent Developments
  • 7.7 Epistem Holdings Plc
    • 7.7.1 Company Overview
    • 7.7.2 Financial Overview
    • 7.7.3 Product Portfolio
    • 7.7.4 Business Strategies
    • 7.7.5 Recent Developments
  • 7.8 Hain Lifescience GmbH
    • 7.8.1 Company Overview
    • 7.8.2 Financial Overview
    • 7.8.3 Product Portfolio
    • 7.8.4 Business Strategies
    • 7.8.5 Recent Developments
  • 7.9 F. Hoffmann-La Roche Ltd.
    • 7.9.1 Company Overview
    • 7.9.2 Financial Overview
    • 7.9.3 Product Portfolio
    • 7.9.4 Business Strategies
    • 7.9.5 Recent Developments
  • 7.10 Hologic, Inc.
    • 7.10.1 Company overview
    • 7.10.2 Financial Overview
    • 7.10.3 Product Portfolio
    • 7.10.4 Business Strategies
    • 7.10.5 Recent Developments
  • 7.11 Sanofi
    • 7.11.1 Company Overview
    • 7.11.2 Financial Overview
    • 7.11.3 Product Portfolio
    • 7.11.4 Business Strategies
    • 7.11.5 Recent Developments
  • 7.12 Thermo Fisher Scientific, Inc.
    • 7.12.1 Company Overview
    • 7.12.2 Financial Overview
    • 7.12.3 Product Portfolio
    • 7.12.4 Business Strategies
    • 7.12.5 Recent Developments
  • 7.13 QIAGEN
    • 7.13.1 Company Overview
    • 7.13.2 Financial Overview
    • 7.13.3 Product portfolio
    • 7.13.4 Business Strategies
    • 7.13.5 Recent Developments

List of Figures

  • FIG. 1 Tuberculosis Testing: Market Segmentation
  • FIG. 2 Global Tuberculosis Testing Market Revenue, by Test Type, 2013 (USD Million)
  • FIG. 3 Comparative Analysis: Global Tuberculosis Testing Market Revenue, by Geography, 2013 & 2020 (Value %)
  • FIG. 4 Porter's Five Forces Analysis: Global Tuberculosis Testing Market
  • FIG. 5 Value Chain Analysis: Global Tuberculosis Testing Market
  • FIG. 6 Market Attractiveness Analysis: Global Tuberculosis Testing Market, by Geography, 2013
  • FIG. 7 Market Share Analysis, by Key Players: Global Tuberculosis Testing Market, 2013 (Value %)
  • FIG. 8 Heat Map Analysis: Global Tuberculosis Testing Market, by Key Players
  • FIG. 9 Comparative Analysis: Global Tuberculosis Testing Market, by Test Type, 2013 & 2020 (Value %)
  • FIG. 10 Global Smear Microscopy (TB Testing) Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 11 Global Culture Based Tests (TB Testing) Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 12 Global Nucleic Acid Testing (TB Testing) Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 13 Global Tuberculin Skin Tests Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 14 Global Radiography (Chest X-Ray) Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 15 Global Drug Susceptibility Testing Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 16 Global Other TB Testing Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 17 North America Tuberculosis Testing Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 18 Europe Tuberculosis Testing Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 19 Asia Pacific Tuberculosis Testing Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 20 RoW Tuberculosis Testing Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 21 Abbott Laboratories: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 22 Alere, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 23 Becton, Dickinson and Company: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 24 bioMérieux SA: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 25 Cepheid: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 26 Epistem Holdings Plc: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 27 F. Hoffmann-La Roche Ltd.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 28 Hologic, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 29 Sanofi: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 30 Thermo Fisher Scientific, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 31 QIAGEN: Annual Revenue, 2011 - 2013 (USD Million)

List of Tables

  • TABLE 1 Market Snapshot: Global Tuberculosis Testing Market
  • TABLE 2 Global Tuberculosis Testing Market Revenue, by Test Type, 2012 - 2020 (USD Million)
  • TABLE 3 Global Tuberculosis Testing Market Revenue, by Geography, 2012 - 2020 (USD Million)
  • TABLE 4 North America Tuberculosis Testing Market Revenue, by Test Type, 2012 - 2020 (USD Million)
  • TABLE 5 Europe Tuberculosis Testing Market Revenue, by Test Type, 2012 - 2020 (USD Million)
  • TABLE 6 Asia Pacific Tuberculosis Testing Market Revenue, by Test Type, 2012 - 2020 (USD Million)
  • TABLE 7 RoW Tuberculosis Testing Market Revenue, by Test Type, 2012 - 2020 (USD Million)
Back to Top